Breviscapine Participates in the Progression of Prostate Cancer by Inhibiting ZFP91 Expression through Upregulation of MicroRNA-129-5p

Figure 1

Breviscapine inhibits proliferation and migration of prostate cancer cells. (a) After treatment with 20, 40, and 80 μg/ml breviscapine for 24 h, the cell proliferation ability of LNCap and PC3 cells was significantly inhibited in a concentration-dependent manner. (b) The proliferation ability of cells was significantly inhibited after treatment of LNCap and PC3 cells with 40 μg/mL breviscapine. (c) Treatment with 40 μg/mL breviscapine significantly inhibited the migration ability of LNCap and PC3 cells (, , and ).

(a)

(b)

(c)